3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications
Publication date
2019-07-01
Authors
Lauschke, Volker M.
Shafagh, Reza Z.
Hendriks, Delilah F.G.
Ingelman-Sundberg, Magnus
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Recent research has shown that the maintenance of relevant liver functions ex vivo requires models in which the cells exhibit an in vivo-like phenotype, often achieved by reconstitution of appropriate cellular interactions. Multiple different models have been presented that differ in the cells utilized, media, and culture conditions. Furthermore, several technologically different approaches have been presented including bioreactors, chips, and plate-based systems in fluidic or static media constituting of chemically diverse materials. Using such models, the ability to predict drug metabolism, drug toxicity, and liver functionality have increased tremendously as compared to conventional in vitro models in which cells are cultured as 2D monolayers. Here, the authors highlight important considerations for microphysiological systems for primary hepatocyte culture, review current culture paradigms, and discuss their opportunities for studies of drug metabolism, hepatotoxicity, liver biology, and disease.
Keywords
cytochrome P450, drug metabolism, hepatotoxicity, liver fibrosis, liver-on-a-chip, microfluidic systems, spheroids, steatosis, Applied Microbiology and Biotechnology, Molecular Medicine
Citation
Lauschke, V M, Shafagh, R Z, Hendriks, D F G & Ingelman-Sundberg, M 2019, '3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity : Emerging Culture Paradigms and Applications', Biotechnology Journal, vol. 14, no. 7, 1800347. https://doi.org/10.1002/biot.201800347